Professor, Departments of Medical OncologyandTherapeutics Research and Hematology and Hematopoietic Cell Transplantation
Oncology
Dr. George Somlo, MD
|
|
Give Review
George Somlo, MD is an expert in the field of Oncology. She received 4 awards: "America's Top Doctors", "Top Doctors:LA Area", "America's Top Doctors for Cancer" and "Top Doctors:Southern California". George Somlo is also a published physician. She has 29 paper published. The most recent paper is: Biosimilars: Extrapolating the evidence. A roundtable discussion. George Somlo accepts Medicare.
Publications
- Breast-cancer-secreted miR-122 reprograms glucose metabolism in premetastatic niche to promote metastasis.
- Age-Related Changes in Nanoparticle Albumin-Bound Paclitaxel Pharmacokinetics and Pharmacodynamics: Influence of Chronological Versus Functional Age.
- Pathologic complete response rates in triple-negative, HER2-positive, and hormone receptor-positive breast cancers after anthracycline-free neoadjuvant chemotherapy wi...
- TGFβ Induces "BRCAness" and Sensitivity to PARP Inhibition in Breast Cancer by Regulating DNA-Repair Genes.
- A cell-intrinsic role for TLR2-MYD88 in intestinal and breast epithelia and oncogenesis.
- Distribution Profiling of Circulating MicroRNAs in Serum.
- The effect of aromatase inhibition on the cognitive function of older patients with breast cancer.
- Cancer-Secreted miR-105 Destroys Vascular Endothelial Barriers to Promote Metastasis.
- Barriers to treatment in patients with locally advanced breast cancer.
- Analysis of circulating tumor cells in breast cancer.
- Treatment outcomes in patients with relapsed and refractory multiple myeloma and high-risk cytogenetics receiving single-agent carfilzomib in the PX-171-003-A1 study.
- Conditional survival and cause-specific mortality after autologous hematopoietic cell transplantation for hematological malignancies.
- Dasatinib : a novel therapy for breast cancer?
- Enrollment onto breast cancer therapeutic clinical trials: A tertiary cancer center experience.
- A phase 2 multicentre study of siltuximab, an anti-interleukin-6 monoclonal antibody, in patients with relapsed or refractory multiple myeloma.
- Second primary malignancies after autologous hematopoietic cell transplantation for multiple myeloma.
- Late relapses following reduced intensity allogeneic transplantation in patients with multiple myeloma: a long-term follow-up study.
- Long-term survival after high-dose chemotherapy followed by peripheral stem cell rescue for high-risk, locally advanced/inflammatory, and metastatic breast cancer.
- CCL2 Mediates Cross-talk between Cancer Cells and Stromal Fibroblasts That Regulates Breast Cancer Stem Cells.
- Dose Escalation of Total Marrow Irradiation With Concurrent Chemotherapy in Patients With Advanced Acute Leukemia Undergoing Allogeneic Hematopoietic Cell Transplantat...
- Phase I study of continuous and intermittent schedules of lapatinib in combination with vinorelbine in solid tumors.
- Phase II studies of gemcitabine and cisplatin in heavily and minimally pretreated metastatic breast cancer.
- Image-guided total-marrow irradiation using helical tomotherapy in patients with multiple myeloma and acute leukemia undergoing hematopoietic cell transplantation.
- Molecular profiling including epidermal growth factor receptor and p21 expression in high-risk breast cancer patients as indicators of outcome.
- Human Epidermal Growth Factor Receptor Family-Targeted Therapies in the Treatment of HER2-Overexpressing Breast Cancer.
- Role of SMC1 in Overcoming Drug Resistance in Triple Negative Breast Cancer.
- Cross-kingdom inhibition of breast cancer growth by plant miR159.
- Biosimilars: Extrapolating the evidence. A roundtable discussion.
Doctors Specialties
- Oncology
Accepted Insurances
Awards
- America's Top Doctors
- Top Doctors:LA Area
- America's Top Doctors for Cancer
- Top Doctors:Southern California
Education
-
City of Hope National Medical Center -
Semmelweis University
Hospital
-
City of Hope's Helford Clinical Research Hospital
Drug Facts
| NPI NUMBER | 1831206861 | |
| NPPES Provider LastName | SOMLO | |
| NPPES Provider FirstName | GEORGE | |
| NPPES Provider ZIPCode | 91010 | |
| NPPES Provider State | CA | |
| Specialty Description | Medical Oncology | |
| Total Claim Count | 263.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1831206861 |
| Last Name Of The Provider | SOMLO |
| First Name Of The Provider | GEORGE |
| View All |
Similar Doctors
|
Dr. Sanjay Awasthi, MD
 This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
Dr. Lucille Leong, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Sumanta K. Pal, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
Dr. Vincent Chung, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Amandeep Salhotra, MD
This Doctor is OpenDoctor Recommended.
|